Literature DB >> 22266120

Obtaining of three recombinant antigens of Entamoeba histolytica and evaluation of their immunogenic ability without adjuvant in a hamster model of immunoprotection.

María Cristina González-Vázquez1, Alejandro Carabarin-Lima, Lidia Baylón-Pacheco, Patricia Talamás-Rohana, José Luis Rosales-Encina.   

Abstract

A 30-kDa surface collagen binding protein peroxiredoxin of Entamoeba histolytica (EhCBP30) was evaluated either alone or fused to the chaperone (CHP) or ATPase (ATP) domains of heat shock protein 70 of Trypanosoma cruzi (TcHSP70) as a vaccine candidate in a hamster model of experimental amoebic liver abscess (ALA) development. Three constructs were produced containing the EhCBP30 DNA sequence, one expressing EhCBP30 and two expressing EhCBP30 fused to either CHP or ATP domains of TcHSP70. High purity recombinant proteins rEhCBP30, rEhCBP30-CHP and rEhCBP30-ATP with N-terminal His tag were obtained by single step affinity purification. Hamsters were immunized without adjuvant with the antigenic recombinant proteins and then challenged intrahepatically with E. histolytica trophozoites. A 70% decrease in ALA development was detected in hamsters immunized with rEhCBP30 and rEhCBP30-CHP, while animals immunized with rEhCBP30-ATP did not show a statistically significant decrease in ALA formation compared with non-immunized animals. Histological analysis of liver tissue showed that the inflammatory infiltrate was discrete or moderate in hamsters immunized with rEhCBP30 or rEhCBP30-CHP compared with that observed in control hamsters or hamsters immunized with rEhCBP30-ATP. These results suggest that rEhCBP30 and rEhCBP30-CHP are able to induce an effective immune response that may protect hamsters against ALA development. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266120     DOI: 10.1016/j.actatropica.2011.12.007

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  4 in total

Review 1.  The future for vaccine development against Entamoeba histolytica.

Authors:  Jeanie Quach; Joëlle St-Pierre; Kris Chadee
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

2.  Furanocoumarins from Ruta chalepensis with Amebicide Activity.

Authors:  Aldo Fabio Bazaldúa-Rodríguez; Ramiro Quintanilla-Licea; María Julia Verde-Star; Magda Elizabeth Hernández-García; Javier Vargas-Villarreal; Jesús Norberto Garza-González
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

Review 3.  Peroxynitrite and peroxiredoxin in the pathogenesis of experimental amebic liver abscess.

Authors:  Judith Pacheco-Yepez; Rosa Adriana Jarillo-Luna; Manuel Gutierrez-Meza; Edgar Abarca-Rojano; Bruce Allan Larsen; Rafael Campos-Rodriguez
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

4.  Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.

Authors:  Xiangyang Min; Meng Feng; Yue Guan; Suqin Man; Yongfeng Fu; Xunjia Cheng; Hiroshi Tachibana
Journal:  PLoS Negl Trop Dis       Date:  2016-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.